biospecimen_aliquot__bcr_aliquot_barcode	tcga-e2-a1l8-01a-11d-a13l-09
biospecimen_aliquot__bcr_aliquot_uuid	04a7762f-2cbb-498b-ab4e-921406c1aec0
biospecimen_aliquot__bcr_patient_uuid	eebad74f-5961-4e91-b0eb-157a2f6f952b
biospecimen_aliquot__bcr_sample_barcode	tcga-e2-a1l8-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0108474676
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-03-23
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	5
biospecimen_aliquot__plate_id	a13l
biospecimen_aliquot__plate_row	d
biospecimen_aliquot__quantity	2.08
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	26.00
biospecimen_analyte__a260_a280_ratio	1.91
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-e2-a1l8-01a-11d
biospecimen_analyte__bcr_analyte_uuid	473ede70-9a48-461c-9b7f-5a66d636cd26
biospecimen_analyte__bcr_patient_uuid	eebad74f-5961-4e91-b0eb-157a2f6f952b
biospecimen_analyte__bcr_sample_barcode	tcga-e2-a1l8-01a
biospecimen_analyte__concentration	0.16
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-e2-a1l8
biospecimen_diagnostic_slides__bcr_patient_uuid	eebad74f-5961-4e91-b0eb-157a2f6f952b
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-e2-a1l8-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	842bf73d-2d64-4aba-880d-dbe8f4c2aa19
biospecimen_normal_control__bcr_patient_barcode	tcga-e2-a1l8
biospecimen_normal_control__bcr_patient_uuid	eebad74f-5961-4e91-b0eb-157a2f6f952b
biospecimen_normal_control__ncedna_dna_conc	0.056
biospecimen_normal_control__ncedna_dna_qm	picogreen
biospecimen_normal_control__ncedna_dna_qty	20
biospecimen_normal_control__ncedna_dna_vol	361
biospecimen_portion__bcr_patient_uuid	eebad74f-5961-4e91-b0eb-157a2f6f952b
biospecimen_portion__bcr_portion_barcode	tcga-e2-a1l8-01a-11
biospecimen_portion__bcr_portion_uuid	77287a17-95f2-4a9c-9d18-0d3eaa067420
biospecimen_portion__bcr_sample_barcode	tcga-e2-a1l8-01a
biospecimen_portion__date_of_creation	2011-03-08
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	11
biospecimen_portion__portion_sequence	1
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-e2-a1l8-01a-11d
biospecimen_protocol__bcr_patient_uuid	eebad74f-5961-4e91-b0eb-157a2f6f952b
biospecimen_protocol__bcr_sample_barcode	tcga-e2-a1l8-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	eebad74f-5961-4e91-b0eb-157a2f6f952b
biospecimen_sample__bcr_sample_barcode	tcga-e2-a1l8-01a
biospecimen_sample__bcr_sample_uuid	91657171-7e5e-4a81-9201-d0b2d5806c04
biospecimen_sample__days_to_collection	912
biospecimen_sample__initial_weight	180
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	false
biospecimen_sample__pathology_report_file_name	tcga-e2-a1l8.9aa68c63-2c14-430a-85c0-5a92f7fccd36.pdf
biospecimen_sample__pathology_report_uuid	9aa68c63-2c14-430a-85c0-5a92f7fccd36
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	eebad74f-5961-4e91-b0eb-157a2f6f952b
biospecimen_shipment_portion__bcr_sample_barcode	tcga-e2-a1l8-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	da720181-484f-4eff-8f96-b7e4298c751b
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a17j
biospecimen_shipment_portion__portion_number	21
biospecimen_shipment_portion__portion_sequence	2
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-e2-a1l8-01a-21-a17j-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	2
biospecimen_shipment_portion__shipment_portion_month_of_shipment	8
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	eebad74f-5961-4e91-b0eb-157a2f6f952b
biospecimen_slide__bcr_sample_barcode	tcga-e2-a1l8-01a
biospecimen_slide__bcr_slide_barcode	tcga-e2-a1l8-01a-01-tsa
biospecimen_slide__bcr_slide_uuid	2b88c3e8-d202-4b83-8390-126f33606d7a
biospecimen_slide__image_file_name	tcga-e2-a1l8-01a-01-tsa.2b88c3e8-d202-4b83-8390-126f33606d7a.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	0
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	0
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	0
biospecimen_slide__percent_stromal_cells	40
biospecimen_slide__percent_tumor_cells	60
biospecimen_slide__percent_tumor_nuclei	85
biospecimen_slide__section_location	top
biospecimen_tumor_sample__bcr_patient_barcode	tcga-e2-a1l8
biospecimen_tumor_sample__bcr_patient_uuid	eebad74f-5961-4e91-b0eb-157a2f6f952b
clinical_drug__bcr_drug_barcode	tcga-e2-a1l8-d20582
clinical_drug__bcr_drug_uuid	5d31dd41-67cf-4788-b56f-452f014b7821
clinical_drug__bcr_patient_barcode	tcga-e2-a1l8
clinical_drug__bcr_patient_uuid	eebad74f-5961-4e91-b0eb-157a2f6f952b
clinical_drug__form_completion_date	2012-1-11
clinical_drug__pharma_type_other	phase iii clinical trial
clinical_drug__pharmaceutical_therapy_drug_name	clodronate
clinical_drug__pharmaceutical_therapy_type	other, specify in notes
clinical_drug__pharmaceutical_tx_dose_units	mg/day
clinical_drug__pharmaceutical_tx_ongoing_indicator	yes
clinical_drug__pharmaceutical_tx_started_days_to	211
clinical_drug__pharmaceutical_tx_total_dose_units	mg/day
clinical_drug__prescribed_dose	1600
clinical_drug__regimen_number	3
clinical_drug__route_of_administration	po
clinical_drug__therapy_regimen	adjuvant
clinical_drug__total_dose	1600
clinical_follow_up__bcr_followup_barcode	tcga-e2-a1l8-f20578
clinical_follow_up__bcr_followup_uuid	0b9dbefa-1df5-45d1-89e1-30bb4c92d599
clinical_follow_up__bcr_patient_barcode	tcga-e2-a1l8
clinical_follow_up__bcr_patient_uuid	eebad74f-5961-4e91-b0eb-157a2f6f952b
clinical_follow_up__followup_reason	scheduled follow-up submission
clinical_follow_up__form_completion_date	2012-1-11
clinical_follow_up__last_contact_days_to	1205
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__targeted_molecular_therapy	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_omf__bcr_omf_barcode	tcga-e2-a1l8-o9156
clinical_omf__bcr_omf_uuid	085892ef-745b-4bdf-ae84-ca00909db5d2
clinical_omf__bcr_patient_barcode	tcga-e2-a1l8
clinical_omf__bcr_patient_uuid	eebad74f-5961-4e91-b0eb-157a2f6f952b
clinical_omf__drug_tx_indicator	no
clinical_omf__form_completion_date	2011-3-15
clinical_omf__malignancy_type	synchronous malignancy
clinical_omf__other_malignancy_anatomic_site	breast
clinical_omf__radiation_tx_indicator	no
clinical_patient__age_at_diagnosis	52
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n1a
clinical_patient__ajcc_pathologic_tumor_stage	stage iib
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left upper outer quadrant
clinical_patient__axillary_staging_method	sentinel lymph node biopsy plus axillary dissection
clinical_patient__bcr_patient_barcode	tcga-e2-a1l8
clinical_patient__bcr_patient_uuid	eebad74f-5961-4e91-b0eb-157a2f6f952b
clinical_patient__birth_days_to	-19187
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_positivity_method	allred score 5 + 3 = 8
clinical_patient__er_positivity_scale_other	allred score = 8
clinical_patient__er_status_by_ihc	positive
clinical_patient__ethnicity	not hispanic or latino
clinical_patient__form_completion_date	2011-6-7
clinical_patient__gender	female
clinical_patient__her2_cent17_ratio	1.10
clinical_patient__her2_fish_status	negative
clinical_patient__her2_ihc_percent_positive	40-49%
clinical_patient__her2_ihc_score	2+
clinical_patient__her2_status_by_ihc	equivocal
clinical_patient__histological_type	infiltrating lobular carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	yes
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8520/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2008
clinical_patient__last_contact_days_to	1015
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	13
clinical_patient__lymph_nodes_examined_he_count	2
clinical_patient__margin_status	negative
clinical_patient__menopause_status	post (prior bilateral ovariectomy or >12 mo since lmp with no prior hysterectomy)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	tumor resection
clinical_patient__micromet_detection_by_ihc	no
clinical_patient__patient_id	a1l8
clinical_patient__pr_positivity_define_method	allred score 4 + 3 = 7
clinical_patient__pr_positivity_scale_other	allred score = 7
clinical_patient__pr_status_by_ihc	positive
clinical_patient__prospective_collection	no
clinical_patient__race	black or african american
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	simple mastectomy
clinical_patient__tissue_source_site	e2
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-e2-a1l8
clinical_radiation__bcr_patient_uuid	eebad74f-5961-4e91-b0eb-157a2f6f952b
clinical_radiation__bcr_radiation_barcode	tcga-e2-a1l8-r20585
clinical_radiation__bcr_radiation_uuid	fd3cf554-dce8-4a47-b16b-cfc4d70af7da
clinical_radiation__course_number	1
clinical_radiation__form_completion_date	2012-1-11
clinical_radiation__radiation_adjuvant_fractions_total	33
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	245
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	regional site
clinical_radiation__radiation_therapy_started_days_to	198
clinical_radiation__radiation_therapy_type	external beam
clinical_radiation__radiation_total_dose	6040
clinical_radiation__therapy_regimen	adjuvant
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A1L8-01A-11D-A13L-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-E2-A1L8-01A-11D-A13L-09.bed.meta
manually_curated__id	tcga-e2-a1l8-01a-11d-a13l-09
manually_curated__md5sum	3f2e2b7577fed1c681a1193dd17387d5
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	04a7762f-2cbb-498b-ab4e-921406c1aec0
manually_curated__tumor_tag	brca
